Prime earns first-ever accreditation for pharmacy benefit management
ST. PAUL, Minn., Oct. 3 /PRNewswire/ -- Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today it has achieved URAC Pharmacy Benefit Management (PBM) accreditation.
The URAC PBM accreditation program is designed to encourage PBM industry best practices, promote quality improvement and protect and empower consumers. Prime began its participation with URAC's beta testing process in June 2007. Prime is now URAC accredited. "Prime has worked hard for this achievement. We strive to improve and promote standard practices in the PBM industry," said Prime's Chief Medical Officer and Senior Vice President, Dr. James Hartert. "Prime believes in continuous improvement in the quality of services we provide to our clients and their members. URAC's accreditation is further proof that Prime lives by its business model of providing the highest quality of services, while ensuring efficiency in cost management."
The URAC standards development process is consensus driven, with hundreds of industry experts serving as volunteers to establish and revise appropriate industry benchmarks. "By applying for and receiving URAC accreditation, Prime Therapeutics has demonstrated a commitment to quality health care," said Alan P. Spielman, URAC's President and CEO. "Quality health care is crucial to our nation's welfare and it is important to have organizations that are willing to measure themselves against national standards."
URAC's standards address a range of industry practices including: organizational quality, customer service/communications/disclosure, pharmacy distribution channels, formulary/pharmacy and therapeutics, and drug utilization management.
Prime Therapeutics LLC is a pharmacy benefit management company
dedicated to providing innovative, clinically based, cost-effective
|SOURCE Prime Therapeutics LLC|
Copyright©2007 PR Newswire.
All rights reserved